You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
CLCC Publications
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Appointment
Find a Condition or Treatment
Find a Doctor
Menu
MAIN
Back to Home
About Us
Corporate Profile
Newsroom
Visitors Information
Contact Us
Patient Care
Specialties & Services
Your Clinic Visit
Cancer Information & Patient Support
E-Services
Find a Doctor
Research & Innovation
Research Labs
Programmes
Facilities
Our Researchers
Clinical Trials
SingHealth Research
Education & Training
Overview
Professional Development
Division of Cancer Education
Events
SingHealth Academy
Careers
Sponsorship
Scholarships
Giving
Why Give
Get Involved
Your Gift at Work
Be Informed
Make a Gift
Our Campaign
Volunteer
Specialties & Services
Back to Home
Goh Cheng Liang Proton Therapy Centre
Haematology
Medical Oncology
Surgery & Surgical Oncology, SGH and NCCS
Radiation Oncology
Oncologic Imaging
Supportive & Palliative Care
Comprehensive Liver Cancer Clinic
Cancer Genetics Service
Lung Multidisciplinary Clinic
Nursing
NCCS Oncology @ SKH
NCCS Oncology Clinic @ CGH
Department of Psychosocial Oncology
Cancer Education and Information
Your Clinic Visit
Back to Home
Book an Appointment
When seeing a doctor
Pharmacy
Outpatient Pharmacy
Oncology Pharmacy
Search a medication
FAQ
Medicine
Charges & Payment
Financial Aid
Video Consultation
Cancer Information & Patient Support
Back to Home
For Patients
For Caregivers
Publications
Cancer Information Booklets
In Good Health
Inspirational Patient & Caregiver Awards
Patient Stories
E-Services
Back to Home
Make/Change/Cancel Appointment
Request for Medical Report
Health Buddy App
Find a Doctor
Home
to skip to the main content on a page
to skip to the main content on a page
About Us
Back to Home
Corporate Profile
Vision & Mission
NCCS Leadership
Annual Report
Awards
Key Milestones
Whistle-blowing Policy
Newsroom
Press Releases
Check Fake News
Visitors Information
Contact Us
Feedback Form
Patient Care
Back to Home
Specialties & Services
Goh Cheng Liang Proton Therapy Centre
Haematology
Medical Oncology
Surgery & Surgical Oncology, SGH and NCCS
Radiation Oncology
Oncologic Imaging
Supportive & Palliative Care
Comprehensive Liver Cancer Clinic
Cancer Genetics Service
Lung Multidisciplinary Clinic
Nursing
NCCS Oncology @ SKH
NCCS Oncology Clinic @ CGH
Department of Psychosocial Oncology
Cancer Education and Information
Your Clinic Visit
Book an Appointment
When seeing a doctor
Pharmacy
Medicine
Charges & Payment
Financial Aid
Video Consultation
Cancer Information & Patient Support
For Patients
For Caregivers
Publications
Patient Stories
E-Services
Make/Change/Cancel Appointment
Request for Medical Report
Health Buddy App
Find a Doctor
Research & Innovation
Back to Home
Research Labs
Cellular & Molecular Research
Medical Sciences
Clinical Trials & Epidemiological Sciences
NCCS Research Committee & Scientific Advisory Board
Research Divisions Organisation Chart
Programmes
Disease Focus
Research Themes
Joint Breast Cancer Registry
Asia-Pacific Hepatocellular Carcinoma Trials Group
The VICTORY Consortium
Facilities
Overview
Specialised Units
Shared Facilities
Shared Services
Research Contracts and Commercialisation
Our Researchers
Division of Medical Oncology
Division of Surgery & Surgical Oncology, SGH and NCCS
Division of Radiation Oncology
Division of Oncologic Imaging
Division of Supportive and Palliative Care
Cellular and Molecular Research
Division of Medical Sciences
Clinical Trials & Epidemiological Sciences
Research Biennial Book
Clinical Trials
About Clinical Trials
Current Clinical Trials
ECRU
About Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics and Epidemiology Unit
SingHealth Research
Education & Training
Back to Home
Overview
Professional Development
Continuing Medical Education
Continuing Nursing Education
Continuing Pharmacist Education
Division of Cancer Education
Undergraduate Education Unit
Postgraduate Education Unit
Nursing & Allied Health Education Unit
Faculty Development & Support Education Unit
Primary Care Oncology Education Unit
Communications, Mentoring, Ethics and Professionalism Education Unit
Medical Humanities Education Unit
Events
SingHealth Academy
Careers
Back to Home
Sponsorship
Career Conversion Programme
Scholarships
Giving
Back to Home
Why Give
About Us
Funding Innovative Research
Preventing Cancer
Advancing Medical Education
Helping Our Patients
Furthering Donor Impact
How Your Gift Helps
Get Involved
Honouring Your Gift
Become a Corporate Donor
Leave Your Legacy
Fundraise for Us
Join a Special Event
Your Gift at Work
Stories of Hope
Researchers in Action
Support for Patients
Our Work in the Community
Training Future Experts
Be Informed
Our Publications
Financial Statements
Make a Gift
Our Campaign
Make More Survivors
Jeans For Genes
Women VS Cancer
BCAM 2023
LCAM 2023
Volunteer
Home
>
Patient Care
>
Specialties & Services
>
Publications
Publications
Facebook
WhatsApp
Email Us
share
Font Resize
A-
A
A+
Print
By:
Comprehensive Liver Cancer Clinic
About Us
Our Clinical Services
List of Publications
Useful Links
Page Content
List of Publications
Clinical
1
Cost-Effectiveness Analysis of Liver Resection Versus Transplantation for Early Hepatocellular Carcinoma within the Milan Criteria. Lim, K. C., V. W. Wang, F. J. Siddiqui, L. M. Shi, S. Y. Chan, H. C. Oh, S. B. Tan, and P. K. Chow. Hepatology, (2014) 10.1002/hep.27135.
2
Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma . Chow, Pierce K. H., Donald Y. H. Poon, Maung-Win Khin, Harjit Singh, Ho-Seong Han, Anthony S. W. Goh, Su-Pin Choo, Hee-Kit Lai, Richard H. G. Lo, Kiang-Hiong Tay, Teong-Guan Lim, Mihir Gandhi, Say-Beng Tan, Khee-Chee Soo, and Group for the Asia-Pacific Hepatocellular Carcinoma Trials. PLoS ONE 9, no. 3 (2014): e90909.
3
Survival and Pattern of Tumor Progression with Yttrium-90 Microsphere Radioembolization in Predominantly Hepatitis B Asian Patients with Hepatocellular Carcinoma . Khor, AndrewYu-Keat, Ying Toh, JohnCarson Allen, DavidChee-Eng Ng, Yung-Hsiang Kao, Guili Zhu, Su-Pin Choo, RichardHoau-Gong Lo, Kiang-Hiong Tay, Jin-Yao Teo, BrianKim-Poh Goh, MarkChristiaan Burgmans, FarahGillian Irani, AnthonySoon-Whatt Goh, and PierceKah-Hoe Chow. Hepatology International, (2014): 1936-0541
4
Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90. Lau, W. Y., B. Sangro, P. J. Chen, S. Q. Cheng, P. Chow, R. C. Lee, T. Leung, K. H. Han, and R. T. Poon. Oncology 84, no. 5 (2013): 311-8.
5
Systematic Review of Outcomes of Liver Resection for Early Hepatocellular Carcinoma within the Milan Criteria. Lim, K. C., P. K. Chow, J. C. Allen, F. J. Siddiqui, E. S. Chan, and S. B. Tan. Br J Surg 99, no. 12 (2012): 1622-9.
6
Activity of Thalidomide and Capecitabine in Patients with Advanced Hepatocellular Carcinoma. SF Ang, SH Tan, HC Toh, DYH Poon, SYK Ong, KF Foo , SP Choo Am J Clin Oncol 2011, Mar2 ( in press) [IF 2.206]
7
Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria . Lim, K. C., P. K. Chow, J. C. Allen, G. S. Chia, M. Lim, P. C. Cheow, A. Y. Chung, L. L. Ooi, and S. B. Tan. Ann Surg 254, no. 1 (2011): 108-13.]
8
Randomised Double-Blind Trial of Megestrol Acetate Vs Placebo in Treatment-Naive Advanced Hepatocellular Carcinoma. Chow, P. K., D. Machin, Y. Chen, X. Zhang, K. M. Win, H. H. Hoang, B. D. Nguyen, M. Y. Jin, R. Lobo, M. Findlay, C. H. Lim, S. B. Tan, M. Gandhi, and K. C. Soo. Br J Cancer 105, no. 7 (2011): 945-52.
9
A Novel Approach to Brachytherapy in Hepatocellular Carcinoma Using a Phosphorous32 (32p) Brachytherapy Delivery Device—a First-in-Man Study . Goh, Anthony Soon-Whatt, Alexander Yaw-Fui Chung, Richard Houa-Gong Lo, Te-Neng Lau, Sidney Wing-Kwong Yu, May Chng, Somanesan Satchithanantham, Susan Li-Er Loong, David Chee-Eng Ng, Beng-Choo Lim, Stephen Connor, and Pierce Kah-Hoe Chow. International journal of radiation oncology, biology, physics 67, no. 3 (2007): 786-792.
10
High-Dose Tamoxifen in the Treatment of Inoperable Hepatocellular Carcinoma: A Multicenter Randomized Controlled Trial. Chow, P. K., B. C. Tai, C. K. Tan, D. Machin, K. M. Win, P. J. Johnson, and K. C. Soo. Hepatology 36, no. 5 (2002): 1221-6.
Translational
1
Deep Sequencing of the Hepatitis B Virus in Hepatocellular Carcinoma Patients Reveals Enriched Integration Events, Structural Alterations and Sequence Variations. Toh, S. T., Y. Jin, L. Liu, J. Wang, F. Babrzadeh, B. Gharizadeh, M. Ronaghi, H. C. Toh, P. K. Chow, A. Y. Chung, L. L. Ooi, and C. G. Lee. Carcinogenesis 34, no. 4 (2013): 787-98.
2
Altered Binding Site Selection of P53 Transcription Cassettes by Hepatitis B Virus X Protein. Chan, C., Y. Wang, P. K. Chow, A. Y. Chung, L. L. Ooi, and C. G. Lee. Mol Cell Biol 33, no. 3 (2013): 485-97.
3
Microrna-224 Is up-Regulated in Hepatocellular Carcinoma through Epigenetic Mechanisms. Wang, Y., H. C. Toh, P. Chow, A. Y. Chung, D. J. Meyers, P. A. Cole, L. L. Ooi, and C. G. Lee. FASEB J 26, no. 7 (2012): 3032-41.
4
Dovitinib demonstrates antitumor and antimetastatic activitiesin xenograft models of hepatocellular carcinoma. Huynh, H, P.K. Chow, W. M. Tai, S. P. Choo, A.Y.F.Chung, H.S.Ong, K.C.Soo, R.Ong, R.Linnartz, M.M.Shi. J Hepatol (2012) 56(3):595-601
5
Azd6244 Enhances the Anti-Tumor Activity of Sorafenib in Ectopic and Orthotopic Models of Human Hepatocellular Carcinoma (HCC). Huynh, H., V. C. Ngo, H. N. Koong, D. Poon, S. P. Choo, H. C. Toh, C. H. Thng, P. Chow, H. S. Ong, A. Chung, B. C. Goh, P. D. Smith, and K. C. Soo. J Hepatol 52, no. 1 (2010): 79-87. [IF 7.818]
6
Lethal-7 Is Down-Regulated by the Hepatitis B Virus X Protein and Targets Signal Transducer and Activator of Transcription 3. Wang, Y., Y. Lu, S. T. Toh, W. K. Sung, P. Tan, P. Chow, A. Y. Chung, L. L. Jooi, and C. G. Lee. J Hepatol 53, no. 1 (2010): 57-66.
7
Sorafenib and Rapamycin Induce Growth Suppression in Mouse Models of Hepatocellular Carcinoma. Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Thng CH, Chow P, Ong HS, Chung A, Soo K.C J Cell Mol Med. 2009 Aug;13(8B):2673-83.[IF 6.807]
8
RAD001 (everolimus) inhibits tumor growth in xenograft models of human hepatocellular carcinoma. Hung H, KH P Chow, KC Soo, HC Toh, SP Choo, KF Foo, DPoon, VC Ngo,E Tran. J Cell Mol Med. 2009;13(7):1371-80. [IF6.807]
9
Sunitinib (Sutent, Su11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma. Huynh, H., V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P. Chang, H. S. Ong, A. Y. Chung, P. K. Chow, and K. C. Soo. Curr Cancer Drug Targets 9, no. 6 (2009): 738-47. [IF 5.129]
10
Effective Inhibition of Xenografts of Hepatocellular Carcinoma (Hepg2) by Rapamycin and Bevacizumab in an Intrahepatic Model. Ong, L. C., I. C. Song, Y. Jin, I. H. Kee, E. Siew, S. Yu, C. H. Thng, H. Huynh, and P. K. Chow. Mol Imaging Biol 11, no. 5 (2009): 334-42.
2/24/2021 11:04 AM
×
SUBSCRIBE VIA EMAIL
Subscribe to our mailing list to get the updates to your email inbox...
Find a Doctor
Condition & Treatment
Home
Appointment
E-services